上海吉尔生化 www.glschina.com
由国际知名药物化学家、美国麻省大学乔治·怀特教授及两位留美博士亲自参与组建的吉尔生化（上海）有限公司，是一家以多肽、多肽原料、多肽合成方法学为重点发展领域的外商独资企业。

主要产品

多肽

多肽药物

cGMP多肽

多肽试剂

缩合剂——BOP reagent, PyBOP, HBTU, TBTU, HOBt,EDC·HCl...

保护剂——Fmoc-OSu, Fmoc-Cl, Z-OSu...

用于固相合成的链接剂——DHP linker, HMP linker, Sieber linker, Rink amide linker, Weinreb amide linker...

Boc-氨基酸，Fmoc-氨基酸，Z-氨基酸

非天然氨基酸

Fmoc-氨基酸王树脂

自1998年成立以来，吉尔生化经历了快速的发展。公司凭借一批优秀技术骨干和高级管理人才，快速应对国际市场需求，研究开发了一系列的新产品。特别是各类多肽试剂，已经在国际市场上得到了广泛的认可。目前，公司又在中国市场推出了多肽合成业务，并积极资助和参与中国的多肽学术活动，推动中国多肽事业的发展。

目前,公司员工人数超过700人,直接从事多肽合成的一线人员增加至300人，另有一支150多人组成的高效液相色谱纯化队伍，公司除通过人工合成技术外,还采用自动多肽合成设备 ，96、106孔自动多肽合成仪、微波多肽合成仪，专门生产毫克级、多序列品种的多肽产品以满足客户的研发需要。 公司每月多肽产量为6000条纯化多肽。我们还开发出不同的固相合成方法以满足商业级别的多肽需求。目前，公司成为中国多肽合成及纯化规模最大、 试剂品种最齐全的企业。

研究领域

研制用于合成多肽醛、多肽醇和多肽酰胺的新型链接剂。

开发高效多肽缩合剂。

多肽化学

吉尔生化从其创建之初就一直受到国家各级领导以及社会各界的关心和支持。党和国家领导人胡锦涛、江泽民、黄菊、朱镕基等热情接见公司高级管理人员。上海市委市政府也鼎立支持公司的发展，市委、市政府等主要领导都曾亲临公司慰问考察。

在新世纪里，吉尔生化将依托现有的和新的优势，真诚地与各方合作，共同发展我们的事业。

 GL Biochem (Shanghai) Ltd. (GLS) is dedicated to the research, development, manufacture and marketing of diverse biochemicals and fine chemicals, especially peptide, peptide reagents and related products.

Featured Products
Peptide coupling reagents: BOP reagent, HBTU, HOBt, TBTU...
Fmoc-amino acids, Boc-Amino Acids, Z-Amino Acids
Protecting reagents: Fmoc-Cl, Fmoc-OSu...
Linkers for solid phase synthesis: HMP linker, DHP linker, Rink amide linker...
Unusual amino acids: Homo-tyrosine, DL-m-tyrosine, Nal, Pal, 4-Cl-Phe-OH...
Generic Peptide: Octreotide, Leuprolide ...
cGMP Peptide
Featured Services
Custom Organic Synthesis
Custom Peptide Synthesis
contract research
With the well trained technical staff and full access to state-of-the-art facilities, such as 300 MHz NMR, LC-MS, IR, Chiral & RP HPLC, High Pressure Hydrogenator ,96 well peptide synthesizer, 106 well peptide synthesizer and Microwave Peptide Synthesizer GLS possesses the powerful research and development capability for new products, and assurance of product quality.

GL Biochem has a state-of-the art 17,000 sq.meter size manufacturing facility for the production of peptide reagents and peptide. The facility has various kinds of reactors with an annual capacity of 100MT for peptide reagents, 120kg for cGMP peptides Moreover, we have also equipped our plant with a lot of sophisticated equipment which include more than 100 units of preparative HPLC system and analytical HPLC system.

At the moment, the company has more than 700 staff, total of 300 plus chemists directly involved in peptide synthesis, with additional 150 plus technicians in HPLC purification. In addition to having well established, manual synthesis techniques, GL Biochem also invests in units of Automated Multiple Peptide Synthesizers to support customers in peptidomimetics studies and drug discovery for milligram scale of a large number of related peptides and peptidomimetics.

The company probably possesses the biggest capacity with state-of-the art facilities in custom peptides in the world.

During the past few years, GLS has presented a wide range of products to customers in different industries and research communities worldwide, and has provided custom synthesis services to satisfy their special demands. Because of the high quality, on-time delivery and competitive prices, GLS products have been well received by reputed peptide and pharmaceutical companies worldwide